Document Detail


The effect of bopindolol on lipids and platelet aggregation.
MedLine Citation:
PMID:  3229118     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
An open ambulatory study was performed to assess the effect of bopindolol in 19 hypertensive patients (W.H.O. stage I-II). A statistically significant decrease in systolic and diastolic pressure as well as heart rate (never below 60 beats per minute) was demonstrated. No undesirable subjective side-effects of the drug were reported. Compared with the serum concentrations after placebo, a decrease in all low-density fractions was observed after 12 months. The total cholesterol/HDL cholesterol ratio did not deteriorate and the apolipoprotein A/apolipoprotein B ratio increased. The values of triacylglycerols during 8 months of therapy did not exceed initial serum concentrations following placebo administration. Patients treated with bopindolol exhibited decreased platelet aggregation due to collagen.
Authors:
E Pintérová; J Kacerovský; Z Zadák; J Malý; V Pidrman
Related Documents :
9243148 - The structural arteriolar changes in diabetes mellitus and essential hypertension. the ...
19963158 - Pequi fruit (caryocar brasiliense camb.) pulp oil reduces exercise-induced inflammatory...
22821198 - The effects of homocysteine-related compounds on cardiac contractility, coronary flow, ...
7282308 - Effects of natural estrogen/gestagen and thiazide on coronary risk factors in normal po...
9780618 - Nitrate tolerance in patients with effort angina.
3762138 - Manometric evaluation of the feline esophagus.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Cor et vasa     Volume:  30     ISSN:  0010-8650     ISO Abbreviation:  Cor Vasa     Publication Date:  1988  
Date Detail:
Created Date:  1989-04-14     Completed Date:  1989-04-14     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0372614     Medline TA:  Cor Vasa     Country:  CZECHOSLOVAKIA    
Other Details:
Languages:  eng     Pagination:  352-60     Citation Subset:  IM    
Affiliation:
2nd Department of Medicine, Teaching Hospital J.E. Purkynĕ Military Research, Hradec Králové, Czechoslovakia.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Aged
Antihypertensive Agents / pharmacology*,  therapeutic use
Heart Rate / drug effects
Humans
Lipids / blood*
Middle Aged
Pindolol / analogs & derivatives*,  pharmacology,  therapeutic use
Platelet Aggregation / drug effects*
Chemical
Reg. No./Substance:
0/Antihypertensive Agents; 0/Lipids; 13523-86-9/Pindolol; 69010-88-4/bopindolol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Deep vein thrombosis and its prevention in patients with acute myocardial infarction.
Next Document:  Detection of elastin-antielastin circulating immune complexes (CIC) in diabetic patients with vascul...